These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2595783)

  • 1. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.
    Taylor CJ; Chapman JR; Ting A; Morris PJ
    Transplantation; 1989 Dec; 48(6):953-8. PubMed ID: 2595783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.
    Taylor CJ; Chapman JR; Fuggle SV; Ting A; Morris PJ
    Tissue Antigens; 1987 Sep; 30(3):104-12. PubMed ID: 3321555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and significance of donor-reactive B cell antibodies in current sera of kidney transplant patients.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1990 Mar; 49(3):510-5. PubMed ID: 2316012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
    Bryan CF; Baier KA; Nelson PW; Luger AM; Martinez J; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Helling TS; Muruve N
    Transplantation; 1998 Dec; 66(12):1827-32. PubMed ID: 9884283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
    Jeannet M; Benzonana G; Arni I
    Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive crossmatches--when is it safe to transplant?
    Ting A
    Transpl Int; 1989 Apr; 2(1):2-7. PubMed ID: 2765101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of more sensitive ancillary crossmatch techniques in predicting early cadaver renal graft outcome.
    Smit JA; Stark JH; Margolius LP; Botha JR; Thomson PD; Meyers AM; Myburgh JA
    Transpl Int; 1991 Jun; 4(2):77-81. PubMed ID: 1910433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperacute Rejection in a Kidney Transplant With Negative Crossmatch: A Case Report.
    Pereira M; Guerra J; Gonçalves J; Santana A; Nascimento C; da Costa AG
    Transplant Proc; 2016 Sep; 48(7):2384-2386. PubMed ID: 27742303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes.
    Smith JD; Danskine AJ; Rose ML; Yacoub MH
    Transplantation; 1992 Jun; 53(6):1358-62. PubMed ID: 1604491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.